A Potential Role for Dendritic Cell/Macrophage-Expressing DPP4 in Obesity-Induced Visceral Inflammation

Dipeptidyl peptidase-4 (DDP4) inhibitors target the enzymatic degradation of incretin peptides and represent a major advance in the treatment of type 2 diabetes. DPP4 has a number of nonenzymatic functions that involve its interaction with adenosine deaminase (ADA) and other extracellular matrix pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Jixin, Rao, Xiaoquan, Deiuliis, Jeffrey, Braunstein, Zachary, Narula, Vimal, Hazey, Jeffrey, Mikami, Dean, Needleman, Bradley, Satoskar, Abhay R., Rajagopalan, Sanjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Obesity Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526020/
https://www.ncbi.nlm.nih.gov/pubmed/22936179
http://dx.doi.org/10.2337/db12-0230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526020/
https://www.ncbi.nlm.nih.gov/pubmed/22936179
http://dx.doi.org/10.2337/db12-0230

Ejemplares similares